Rafael Amado
CIK 1662119 · See Remarks · last filed 2026-04-08
Rafael Amado is a corporate insider who has filed 44 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing shows the insider sold $56.0K of ZLAB on Apr 8, 2026. Across all open-market trades the lifetime net is −$3.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.76M
5
44
-$3.73M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZLAB | See Remarks | 57,022 | $17.07 | $973.4K | -$2.10M | 18 | 2026-04-08 |
| Poseida Therapeutics, Inc. (PSTX) Delisted | Director | 0 | $9.50 | $0 | $0 | 3 | 2025-01-08 |
| ALLO | EVP of R&D | 541,946 | $1.90 | $1.03M | -$1.59M | 16 | 2022-10-11 |
| ASND | President, R&D | 17,237 | $218.06 | $3.76M | -$39.0K | 6 | 2019-08-07 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Chief Medical Officer | — | $0.06 | — | $0 | 1 | 2016-01-20 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-08 | ZLAB | Sell (S) | −2,739 | -$56.0K | EDGAR |
| 2026-04-03 | ZLAB | Mixed | +15,004 | -$202.1K | EDGAR |
| 2026-03-16 | ZLAB | Mixed | +2,366 | -$55.1K | EDGAR |
| 2026-03-05 | ZLAB | Sell (S) | −10,000 | -$173.8K | EDGAR |
| 2026-01-02 | ZLAB | Mixed | +10,213 | -$188.0K | EDGAR |
| 2025-08-12 | ZLAB | Sell (S) | −3,000 | -$105.0K | EDGAR |
| 2025-04-07 | ZLAB | Mixed | +2,362 | -$100.3K | EDGAR |
| 2025-04-03 | ZLAB | Mixed | +11,982 | -$270.7K | EDGAR |
| 2025-03-19 | ZLAB | Sell (S) | −3,000 | -$115.2K | EDGAR |
| 2025-03-14 | ZLAB | Grant (A) | — | $0 | EDGAR |